Monash harnesses new frontier in technology to propel promising local drug discoveries
Posted: 17 November 2023 The Monash Institute of Pharmaceutical Sciences (MIPS) has unveiled a brand new instrument – the Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer (MS) – which will play a key role in enabling the team to efficiently identify…
Monash University joins Uniseed to supercharge innovation success
Posted: 17 November 2023 Monash University has officially joined the Uniseed investment fund in a collaboration designed to enhance innovation opportunities by amplifying the growth of current and future startup and spinout companies. As a result of Monash…
Burnet Institute enters into a Research Licence and Option Agreement for Stellabody® – a biologic and antibody therapeutics platform – with argenx
Posted: 17 November 2023 Burnet Institute has entered into a research licence and option agreement for Burnet Institute’s Stellabody® technology with argenx. The Stellabody® platform Stellabody® is a unique on-target hexamerisation technology that exploits a natural property of…
White Paper offers roadmap to a vibrant Victorian medtech sector
Posted: 17 November 2023 The Victorian Medtech Skills and Devices Hub (VMH) has released a White Paper identifying the education and training needed to accelerate the growth of Victoria’s vibrant medtech industry. An initiative of the Victorian Government’s Australian Medtech…
Monash engineers make discovery that gives babies with hearing impairment new hope
Posted: 17 November 2023 Monash University Electrical and Computer Systems Engineering and Bionics Institute research teams have used cutting edge light technology invisible to the human eye to non-invasively image brains to help diagnose hearing impairments in infants and prescribe…
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
Posted: 14 November 2023 Telix today announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio-antibody drug conjugate (rADC) therapy, TLX591 (177Lu-rosopatamab tetraxetan).…
Neuren completes Phelan-McDermid syndrome Phase 2 trial
Posted: 14 November 2023 Neuren Pharmaceuticals (ASX: NEU) today announced that all study visits are complete in its Phase 2 clinical trial of NNZ-2591 in Phelan-McDermid syndrome (PMS). Top-line results from the trial are expected to be available…
Neuren receives Australian Growth Company of the Year Award
Posted: 14 November 2023 Neuren Pharmaceuticals (ASX: NEU) has been presented with the 2023 Australian Growth Company of the Year Award for Health and Life Sciences. Neuren CEO Jon Pilcher commented: “We were very pleased to be recognized…
A “massive leap”: New test for blood cancer funded by MBS
Posted: 13 November 2023 Peter Mac scientists have been part of a nationwide push to get an important genetic test for blood cancer funded by Medicare. Approved by the federal government earlier this year and now funded in…
The Australian names Monash University number one in research for 2024
Posted: 13 November 2023 Monash University has been named Australia’s top research institution by The Australian in its annual list of the country’s top researchers and research institutions. Of the 250 fields of academic endeavour identified by The Australian Research Magazine…
mRNA research to accelerate through new network
Posted: 13 November 2023 Peter Mac will be part of a pioneering initiative driven by Moderna to bring together key Australian medical research institutes to form a mRNA Platform Incubator Network. The mRNA Platform Incubator Network aims to…
National centre to transform home-grown medicine capabilities launched in Melbourne
Posted: 13 November 2023 MedChem Australia will accelerate promising early-stage drug discovery projects towards clinical trials and, ultimately, create new medicines for a broad range of diseases. The first-of-its-kind national initiative connecting three of Australia’s top medicinal chemistry…
